Michael Gold to Defibrillators, Implantable
This is a "connection" page, showing publications Michael Gold has written about Defibrillators, Implantable.
Connection Strength
32.426
-
Infection in patients with subcutaneous implantable cardioverter-defibrillator: Results of the S-ICD Post Approval Study. Heart Rhythm. 2022 Dec; 19(12):1993-2001.
Score: 0.613
-
Can We Treat an Older Patient With a New Trick? J Am Coll Cardiol. 2022 03 22; 79(11):1060-1062.
Score: 0.597
-
The cost of non-response to cardiac resynchronization therapy: characterizing heart failure events following cardiac resynchronization therapy. Europace. 2021 10 09; 23(10):1586-1595.
Score: 0.579
-
Primary Results From the Understanding Outcomes With the S-ICD in Primary Prevention Patients With Low Ejection Fraction (UNTOUCHED) Trial. Circulation. 2021 01 05; 143(1):7-17.
Score: 0.541
-
1-Year Prospective Evaluation of Clinical Outcomes and Shocks: The?Subcutaneous?ICD?Post?Approval Study. JACC Clin Electrophysiol. 2020 11; 6(12):1537-1550.
Score: 0.536
-
Relationship of Shock Energy to Impedance During Subcutaneous Implantable Cardioverter-Defibrillator Testing. Circ Arrhythm Electrophysiol. 2020 09; 13(9):e008631.
Score: 0.532
-
Outcomes of subcutaneous implantable cardioverter-defibrillator in dialysis patients: Results from the S-ICD post-approval study. Heart Rhythm. 2020 09; 17(9):1566-1574.
Score: 0.524
-
Electromagnetic interference from left ventricular assist devices in patients with subcutaneous implantable cardioverter-defibrillators. J Cardiovasc Electrophysiol. 2020 05; 31(5):1195-1201.
Score: 0.519
-
Editorial commentary: The subcutaneous ICD: An expanding niche or the future of implantable defibrillators? Trends Cardiovasc Med. 2020 08; 30(6):385-386.
Score: 0.506
-
Electrocardiogram in Cardiac?Resynchronization Therapy: Is Non-Left Bundle Branch Block an Oversimplification? J Am Coll Cardiol. 2019 06 25; 73(24):3100-3101.
Score: 0.494
-
Understanding Outcomes with the EMBLEM S-ICD in Primary Prevention Patients with Low EF Study (UNTOUCHED): Clinical characteristics and perioperative results. Heart Rhythm. 2019 11; 16(11):1636-1644.
Score: 0.490
-
A Substernal Defibrillator Lead?With?Pacing Capability: Another Tool in the Toolbox? JACC Clin Electrophysiol. 2019 02; 5(2):197-198.
Score: 0.481
-
Anesthesia for subcutaneous implantable cardioverter-defibrillator implantation: Perspectives from the clinical experience of a U.S. panel of physicians. Pacing Clin Electrophysiol. 2018 07; 41(7):807-816.
Score: 0.459
-
Use of antibiotic envelopes to prevent cardiac implantable electronic device infections: A meta-analysis. J Cardiovasc Electrophysiol. 2018 04; 29(4):609-615.
Score: 0.451
-
Subcutaneous implantable cardioverter-defibrillator Post-Approval Study: Clinical characteristics and perioperative results. Heart Rhythm. 2017 10; 14(10):1456-1463.
Score: 0.426
-
ICD Utilization: Can We Select the Right Patients? JACC Clin Electrophysiol. 2017 03; 3(3):299-301.
Score: 0.422
-
The Design of the Understanding Outcomes with the S-ICD in Primary Prevention Patients with Low EF Study (UNTOUCHED). Pacing Clin Electrophysiol. 2017 Jan; 40(1):1-8.
Score: 0.417
-
The Effect of Chronic Kidney Disease on Mortality with Cardiac Resynchronization Therapy. Pacing Clin Electrophysiol. 2016 Aug; 39(8):863-9.
Score: 0.400
-
Impact of magnetic resonance imaging on ventricular tachyarrhythmia sensing: Results of the Evera MRI Study. Heart Rhythm. 2016 08; 13(8):1631-5.
Score: 0.398
-
Safety and Efficacy of the Subcutaneous Implantable Defibrillator. J Am Coll Cardiol. 2016 Feb 02; 67(4):445-454.
Score: 0.390
-
Biventricular pacemaker/defibrillators versus biventricular pacemakers in patients with non-ischemic cardiomyopathy. Card Electrophysiol Clin. 2015 Sep; 7(3):455-9.
Score: 0.374
-
Full-Body MRI in Patients With an Implantable Cardioverter-Defibrillator: Primary Results of a Randomized Study. J Am Coll Cardiol. 2015 Jun 23; 65(24):2581-2588.
Score: 0.371
-
Clinical experience with subcutaneous implantable cardioverter-defibrillators. Nat Rev Cardiol. 2015 Jul; 12(7):398-405.
Score: 0.370
-
A new algorithm to reduce inappropriate therapy in the S-ICD system. J Cardiovasc Electrophysiol. 2015 Apr; 26(4):417-423.
Score: 0.365
-
Preclinical evaluation of implantable cardioverter-defibrillator developed for magnetic resonance imaging use. Heart Rhythm. 2015 Mar; 12(3):631-638.
Score: 0.361
-
Use of a discrimination algorithm to reduce inappropriate shocks with a subcutaneous implantable cardioverter-defibrillator. Heart Rhythm. 2014 Aug; 11(8):1352-8.
Score: 0.345
-
Newer Indications for ICD and CRT. Cardiol Clin. 2014 May; 32(2):181-90.
Score: 0.341
-
Who should receive the subcutaneous implanted defibrillator?: The subcutaneous implantable cardioverter defibrillator (ICD) should be considered in all ICD patients who do not require pacing. Circ Arrhythm Electrophysiol. 2013 Dec; 6(6):1236-44; discussion 1244-5.
Score: 0.336
-
Implantable defibrillators improve survival in patients with mildly symptomatic heart failure receiving cardiac resynchronization therapy: analysis of the long-term follow-up of remodeling in systolic left ventricular dysfunction (REVERSE). Circ Arrhythm Electrophysiol. 2013 Dec; 6(6):1163-8.
Score: 0.333
-
How many transvenous coils are optimal for defibrillators: one, two, or none? Heart Rhythm. 2013 Jul; 10(7):977-8.
Score: 0.322
-
Influence of intracardiac pressure on spontaneous ventricular arrhythmias in patients with systolic heart failure: insights from the REDUCEhf trial. Circ Arrhythm Electrophysiol. 2013 Apr; 6(2):272-8.
Score: 0.320
-
Safety of continuous anticoagulation with dabigatran during implantation of cardiac rhythm devices. Am J Cardiol. 2013 Apr 15; 111(8):1165-8.
Score: 0.317
-
Is defibrillation testing of ICDs necessary? Nat Rev Cardiol. 2012 Nov; 9(11):618-9.
Score: 0.310
-
Subcutaneous implantable cardioverter defibrillator. Circ Arrhythm Electrophysiol. 2012 Jun 01; 5(3):587-93.
Score: 0.303
-
Hemoglobin spectroscopy to evaluate hemodynamic function during tachycardias: the future of ICD discrimination algorithms? Heart Rhythm. 2012 Oct; 9(10):1592-3.
Score: 0.303
-
Meta-analysis of bleeding complications associated with cardiac rhythm device implantation. Circ Arrhythm Electrophysiol. 2012 Jun 01; 5(3):468-74.
Score: 0.301
-
Interactions between a left ventricular assist device and implantable cardioverter-defibrillator. Pacing Clin Electrophysiol. 2012 Sep; 35(9):e272-3.
Score: 0.299
-
Acute performance of a right ventricular automatic pacing threshold algorithm for implantable defibrillators. Pacing Clin Electrophysiol. 2012 Mar; 35(3):259-68.
Score: 0.293
-
Pre-discharge defibrillation testing: clinically important or obsolete? Europace. 2012 Feb; 14(2):155-6.
Score: 0.291
-
Head-to-head comparison of arrhythmia discrimination performance of subcutaneous and transvenous ICD arrhythmia detection algorithms: the START study. J Cardiovasc Electrophysiol. 2012 Apr; 23(4):359-66.
Score: 0.291
-
Prospective comparison of discrimination algorithms to prevent inappropriate ICD therapy: primary results of the Rhythm ID Going Head to Head Trial. Heart Rhythm. 2012 Mar; 9(3):370-7.
Score: 0.289
-
The relationship between ventricular electrical delay and left ventricular remodelling with cardiac resynchronization therapy. Eur Heart J. 2011 Oct; 32(20):2516-24.
Score: 0.287
-
Economic implications and cost-effectiveness of implantable cardioverter defibrillator and cardiac resynchronization therapy. Heart Fail Clin. 2011 Apr; 7(2):241-50, ix.
Score: 0.279
-
Temporal stability of defibrillation thresholds with cardiac resynchronization therapy. Heart Rhythm. 2011 Jul; 8(7):1008-13.
Score: 0.276
-
To the Editor: Optimizing right ventricular lead position for defibrillation. Heart Rhythm. 2012 Dec; 9(12):e26-7.
Score: 0.275
-
Defibrillation thresholds in hypertrophic cardiomyopathy. J Cardiovasc Electrophysiol. 2011 May; 22(5):569-72.
Score: 0.272
-
Cardiac resynchronization therapy in mild heart failure: a review of the REVERSE and MADIT-CRT trials. Curr Cardiol Rep. 2010 Sep; 12(5):367-73.
Score: 0.268
-
Response to Coceani: Has CRT earned a class I recommendation? Circ Heart Fail. 2010 Jul; 3(4):559-60.
Score: 0.265
-
Randomized comparison of defibrillation thresholds from the right ventricular apex and outflow tract. Heart Rhythm. 2010 Nov; 7(11):1561-6.
Score: 0.264
-
Risk stratification of ventricular arrhythmias in patients with systolic heart failure. Curr Opin Cardiol. 2010 May; 25(3):268-75.
Score: 0.262
-
Defibrillation threshold testing at implantation: can we predict the patient with a high defibrillation threshold? Europace. 2010 Mar; 12(3):309-10.
Score: 0.257
-
Implantable device use in systolic heart failure: lessons learned from IMPROVE HF. Heart Rhythm. 2009 Dec; 6(12):1735-6.
Score: 0.250
-
Defibrillation testing at ICD implantation: are we asking the wrong question? Pacing Clin Electrophysiol. 2009 May; 32(5):567-9.
Score: 0.244
-
Disparities in preferences for receiving support and education among patients with implantable cardioverter defibrillators. Pacing Clin Electrophysiol. 2009 Mar; 32(3):383-90.
Score: 0.242
-
Implantable cardioverter-defibrillator therapy for primary prevention of sudden death after alcohol septal ablation of hypertrophic cardiomyopathy. J Am Coll Cardiol. 2008 Nov 18; 52(21):1718-23.
Score: 0.237
-
Optimization of superior vena cava coil position and usage for transvenous defibrillation. Heart Rhythm. 2008 Mar; 5(3):394-9.
Score: 0.222
-
Comparison of defibrillation efficacy and survival associated with right versus left pectoral placement for implantable defibrillators. Am J Cardiol. 2007 Jul 15; 100(2):243-6.
Score: 0.214
-
Sudden cardiac death: the role of risk stratification. Am Heart J. 2007 Apr; 153(4 Suppl):25-33.
Score: 0.212
-
Dynamic changes of T-wave alternans: does it predict short-term arrhythmia vulnerability? J Cardiovasc Electrophysiol. 2007 May; 18(5):518-9.
Score: 0.212
-
The Rhythm ID Going Head to Head Trial (RIGHT): design of a randomized trial comparing competitive rhythm discrimination algorithms in implantable cardioverter defibrillators. J Cardiovasc Electrophysiol. 2006 Jul; 17(7):749-53.
Score: 0.201
-
Effect of an active abdominal pulse generator on defibrillation thresholds with a dual-coil, transvenous ICD lead system. J Cardiovasc Electrophysiol. 2006 Jun; 17(6):617-20.
Score: 0.200
-
Coronary sinus electrode does not reduce atrial defibrillation thresholds. Heart Rhythm. 2006 Jun; 3(6):647-52.
Score: 0.196
-
Improved defibrillation efficacy with an ascending ramp waveform in humans. Heart Rhythm. 2005 Apr; 2(4):388-94.
Score: 0.184
-
Clinical predictors of atrial defibrillation thresholds with a dual-coil, active pectoral lead system. Heart Rhythm. 2005 Jan; 2(1):49-54.
Score: 0.181
-
Optimization of atrial defibrillation with a dual-coil, active pectoral lead system. J Cardiovasc Electrophysiol. 2004 Jul; 15(7):790-4.
Score: 0.175
-
Comparison of step-down and binary search algorithms for determination of defibrillation threshold in humans. Pacing Clin Electrophysiol. 2004 Feb; 27(2):218-20.
Score: 0.170
-
Effect of shock polarity on defibrillation thresholds with a hybrid patch-coil lead system. J Interv Card Electrophysiol. 2003 Dec; 9(3):391-6.
Score: 0.168
-
Effectiveness of rapid atrial pacing for termination of drug refractory atrial fibrillation: results of a dual chamber implantable cardioverter defibrillator trial. Card Electrophysiol Rev. 2003 Dec; 7(4):341-4.
Score: 0.168
-
Distal right ventricular coil position reduces defibrillation thresholds. J Cardiovasc Electrophysiol. 2003 Oct; 14(10):1036-40.
Score: 0.166
-
Cardiac Resynchronization Therapy Improves Outcomes in Patients With Intraventricular Conduction Delay But Not Right Bundle Branch Block: A Patient-Level Meta-Analysis of Randomized Controlled Trials. Circulation. 2023 Mar 07; 147(10):812-823.
Score: 0.158
-
Safety of a single successful conversion of ventricular fibrillation before the implantation of cardioverter defibrillators. Pacing Clin Electrophysiol. 2003 Jan; 26(1P2):483-6.
Score: 0.158
-
Advanced rhythm discrimination for implantable cardioverter defibrillators using electrogram vector timing and correlation. J Cardiovasc Electrophysiol. 2002 Nov; 13(11):1092-7.
Score: 0.156
-
Efficacy and temporal stability of reduced safety margins for ventricular defibrillation: primary results from the Low Energy Safety Study (LESS). Circulation. 2002 Apr 30; 105(17):2043-8.
Score: 0.150
-
Clinical predictors of defibrillation thresholds with an active pectoral pulse generator lead system. Pacing Clin Electrophysiol. 2002 Apr; 25(4 Pt 1):408-13.
Score: 0.150
-
Lack of benefit of an active pectoral pulse generator on atrial defibrillation thresholds. J Cardiovasc Electrophysiol. 2002 Apr; 13(4):332-5.
Score: 0.150
-
Comparison of the effects of active left and right pectoral pulse generators on defibrillation efficacy. Am J Cardiol. 2001 Dec 01; 88(11):1308-11.
Score: 0.146
-
The importance of early evaluation after cardiac resynchronization therapy to redefine response: Pooled individual patient analysis from 5 prospective studies. Heart Rhythm. 2022 04; 19(4):595-603.
Score: 0.146
-
Temporal Association of Atrial Fibrillation With Cardiac Implanted Electronic Device Detected Heart?Failure Status. JACC Clin Electrophysiol. 2022 02; 8(2):182-193.
Score: 0.146
-
Clinical experience with a dual-chamber implantable cardioverter defibrillator to treat atrial tachyarrhythmias. J Cardiovasc Electrophysiol. 2001 Nov; 12(11):1247-53.
Score: 0.145
-
Positive Psychotherapy Improves Cardiac Electrical Stability and Mood in ICD Patients: PAM-ICD Trial Results. Psychosom Med. 2021 04 01; 83(3):300-301.
Score: 0.140
-
Implantable cardiac defibrillators. Med Clin North Am. 2001 Mar; 85(2):343-67, xi.
Score: 0.139
-
Outcomes of two versus three incision techniques: Results from the subcutaneous ICD post-approval study. J Cardiovasc Electrophysiol. 2021 03; 32(3):792-801.
Score: 0.138
-
Clinical predictors and efficacy of antitachycardia pacing in patients with implantable cardioverter defibrillators: the importance of the patient's sex. Pacing Clin Electrophysiol. 2001 Jan; 24(1):70-4.
Score: 0.137
-
Device-Detected Atrial Fibrillation Before and After Hospitalisation for Noncardiac Surgery or Medical Illness: Insights From ASSERT. Can J Cardiol. 2021 05; 37(5):803-809.
Score: 0.136
-
Primary prevention of sudden cardiac death with implantable cardioverter defibrillators: lessons learned from MADIT and MUSTT. Pacing Clin Electrophysiol. 2000 Nov; 23(11 Pt 2):1981-5.
Score: 0.136
-
Effect of second-phase duration on the strength-duration relation for human transvenous defibrillation. Circulation. 2000 Oct 31; 102(18):2239-42.
Score: 0.136
-
ICD therapy in the new millennium. Cardiol Clin. 2000 May; 18(2):375-89.
Score: 0.131
-
Intracardiac echocardiography use and outcomes after catheter ablation of ventricular tachycardia. J Comp Eff Res. 2020 04; 9(5):375-385.
Score: 0.130
-
Sensing lead failure in implantable defibrillators: a comparison of two commonly used leads. J Cardiovasc Electrophysiol. 2000 Jan; 11(1):21-4.
Score: 0.128
-
Optimization of transvenous coil position for active can defibrillation thresholds. J Cardiovasc Electrophysiol. 2000 Jan; 11(1):25-9.
Score: 0.128
-
Interaction of septadian and circadian rhythms in life-threatening ventricular arrhythmias in patients with implantable cardioverter-defibrillators. Am J Cardiol. 1999 Sep 01; 84(5):555-7.
Score: 0.125
-
Atrial defibrillation with a transvenous lead: a randomized comparison of active can shocking pathways. J Am Coll Cardiol. 1999 Aug; 34(2):358-62.
Score: 0.124
-
Comparison of bipolar and integrated sensing for redetection of ventricular fibrillation. Am Heart J. 1999 Jul; 138(1 Pt 1):133-6.
Score: 0.124
-
Factors Associated With High-Voltage Impedance and Subcutaneous Implantable Defibrillator Ventricular Fibrillation Conversion Success. Circ Arrhythm Electrophysiol. 2019 04; 12(4):e006665.
Score: 0.122
-
The effect of shock configuration and delivered energy on defibrillation impedance. Pacing Clin Electrophysiol. 1999 Jan; 22(1 Pt 2):165-8.
Score: 0.119
-
A new defibrillator discrimination algorithm utilizing electrogram morphology analysis. Pacing Clin Electrophysiol. 1999 Jan; 22(1 Pt 2):179-82.
Score: 0.119
-
A comparison of pectoral and abdominal transvenous defibrillator implantation: analysis of costs and outcomes. J Interv Card Electrophysiol. 1998 Dec; 2(4):345-9.
Score: 0.119
-
Inappropriate shocks from implanted cardioverter defibrillators caused by sensing of diaphragmatic myopotentials. J Interv Card Electrophysiol. 1998 Dec; 2(4):367-70.
Score: 0.119
-
Competitive athletes with implantable cardioverter-defibrillators-How to program? Data from the Implantable Cardioverter-Defibrillator Sports Registry. Heart Rhythm. 2019 04; 16(4):581-587.
Score: 0.118
-
Noninvasive tissue adhesive for cardiac implantable electronic device pocket closure: the TAPE pilot study. J Interv Card Electrophysiol. 2019 Mar; 54(2):171-176.
Score: 0.118
-
Effect of shock polarity on biphasic defibrillation thresholds using an active pectoral lead system. J Cardiovasc Electrophysiol. 1998 Apr; 9(4):350-4.
Score: 0.113
-
Temporal stability of defibrillation thresholds with an active pectoral lead system. J Cardiovasc Electrophysiol. 1998 Mar; 9(3):240-4.
Score: 0.113
-
Lead system optimization for transvenous defibrillation. Am J Cardiol. 1997 Nov 01; 80(9):1163-7.
Score: 0.110
-
Effect of biphasic waveforms on transvenous defibrillation thresholds in patients with coronary artery disease. Am J Cardiol. 1997 Oct 15; 80(8):1098-100.
Score: 0.110
-
Induction of atrial fibrillation with low-energy defibrillator shocks in patients with implantable cardioverter defibrillators. Am J Cardiol. 1997 Oct 01; 80(7):960-2.
Score: 0.110
-
Subcutaneous Versus Transvenous Implantable Defibrillator Therapy: A Meta-Analysis of Case-Control Studies. JACC Clin Electrophysiol. 2017 12 26; 3(13):1475-1483.
Score: 0.109
-
Permanent pacing from the coronary sinus in a patient with an implantable defibrillator. Pacing Clin Electrophysiol. 1997 Sep; 20(9 Pt 1):2286-7.
Score: 0.109
-
Biphasic waveforms prevent the chronic rise of defibrillation thresholds with a transvenous lead system. J Am Coll Cardiol. 1997 Jul; 30(1):233-6.
Score: 0.108
-
Clinical predictors of transvenous biphasic defibrillation thresholds. Am J Cardiol. 1997 Jun 15; 79(12):1623-7.
Score: 0.107
-
Distortion of intracardiac electrograms following defibrillator shocks for atrial tachyarrhythmias. Pacing Clin Electrophysiol. 1997 Jun; 20(6):1682-5.
Score: 0.107
-
Duration of device-detected subclinical atrial fibrillation and occurrence of stroke in ASSERT. Eur Heart J. 2017 May 01; 38(17):1339-1344.
Score: 0.106
-
Predictors of short-term clinical response to cardiac resynchronization therapy. Eur J Heart Fail. 2017 08; 19(8):1056-1063.
Score: 0.105
-
Chronic rise in monophasic defibrillation thresholds with a transvenous lead system. Am J Cardiol. 1997 Feb 15; 79(4):502-5.
Score: 0.105
-
Clinical predictors of transvenous defibrillation energy requirements. Am J Cardiol. 1997 Jan 15; 79(2):150-3.
Score: 0.104
-
Economic Value and Cost-Effectiveness of?Cardiac Resynchronization Therapy Among Patients With Mild Heart Failure: Projections From the REVERSE Long-Term Follow-Up. JACC Heart Fail. 2017 03; 5(3):204-212.
Score: 0.104
-
Complications associated with pectoral implantation of cardioverter defibrillators. World-Wide Jewel Investigators. Pacing Clin Electrophysiol. 1997 Jan; 20(1 Pt 2):208-11.
Score: 0.104
-
Performance of the subcutaneous implantable cardioverter-defibrillator in patients with a primary prevention indication with and without a reduced ejection fraction versus patients with a secondary prevention indication. Heart Rhythm. 2017 03; 14(3):367-375.
Score: 0.103
-
Complications associated with pectoral cardioverter-defibrillator implantation: comparison of subcutaneous and submuscular approaches. Worldwide Jewel Investigators. J Am Coll Cardiol. 1996 Nov 01; 28(5):1278-82.
Score: 0.103
-
Magnetic Resonance Imaging-Conditional External Cardiac Defibrillator: Expanding Access and Safety During Magnetic Resonance Imaging. Circ Cardiovasc Imaging. 2016 10; 9(10).
Score: 0.102
-
Increased Monday incidence of life-threatening ventricular arrhythmias. Experience with a third-generation implantable defibrillator. Circulation. 1996 Sep 15; 94(6):1346-9.
Score: 0.102
-
Effects of an active pectoral-pulse generator shell on defibrillation efficacy with a transvenous lead system. Am J Cardiol. 1996 Sep 01; 78(5):540-3.
Score: 0.102
-
Chronic rise in defibrillation threshold with a hybrid lead system. Am J Cardiol. 1996 Aug 01; 78(3):309-12.
Score: 0.101
-
Effects of waveform and polarity on defibrillation thresholds in humans using a transvenous lead system. Am J Cardiol. 1996 Aug 01; 78(3):313-6.
Score: 0.101
-
Transvenous defibrillation lead systems. J Cardiovasc Electrophysiol. 1996 Jun; 7(6):570-80.
Score: 0.100
-
Image Quality of Cardiac Magnetic Resonance Imaging in Patients With an Implantable Cardioverter Defibrillator System Designed for the Magnetic Resonance Imaging Environment. Circ Cardiovasc Imaging. 2016 May; 9(5).
Score: 0.099
-
Positive Psychotherapy to Improve Autonomic Function and Mood in ICD Patients (PAM-ICD): Rationale and Design of an RCT Currently Underway. Pacing Clin Electrophysiol. 2016 May; 39(5):458-70.
Score: 0.098
-
Evaluation of subcutaneous ICD early performance in hypertrophic cardiomyopathy from the pooled EFFORTLESS and IDE cohorts. Heart Rhythm. 2016 05; 13(5):1066-1074.
Score: 0.097
-
Reduced appropriate implantable cardioverter-defibrillator therapy after cardiac resynchronization therapy-induced left ventricular function recovery: a meta-analysis and systematic review. Eur Heart J. 2015 Nov 01; 36(41):2780-9.
Score: 0.094
-
Safety and Efficacy of the Totally Subcutaneous Implantable Defibrillator: 2-Year Results From a Pooled Analysis of the IDE?Study?and?EFFORTLESS Registry. J Am Coll Cardiol. 2015 Apr 28; 65(16):1605-1615.
Score: 0.093
-
Spurious discharges due to late insulation break in endocardial sensing leads for cardioverter defibrillators. Pacing Clin Electrophysiol. 1995 Mar; 18(3 Pt 1):478-81.
Score: 0.092
-
HRS/ACC/AHA expert consensus statement on the use of implantable cardioverter-defibrillator therapy in patients who are not included or not well represented in clinical trials. Circulation. 2014 Jul 01; 130(1):94-125.
Score: 0.087
-
HRS/ACC/AHA expert consensus statement on the use of implantable cardioverter-defibrillator therapy in patients who are not included or not well represented in clinical trials. Heart Rhythm. 2014 Jul; 11(7):1271-303.
Score: 0.087
-
HRS/ACC/AHA expert consensus statement on the use of implantable cardioverter-defibrillator therapy in patients who are not included or not well represented in clinical trials. J Am Coll Cardiol. 2014 Sep 16; 64(11):1143-77.
Score: 0.087
-
Implantable cardiovertor/defibrillator placement in a patient with amiodarone pulmonary toxicity under thoracic epidural anesthesia. Anesthesiology. 1993 Sep; 79(3):608-11.
Score: 0.083
-
Safety and efficacy of a totally subcutaneous implantable-cardioverter defibrillator. Circulation. 2013 Aug 27; 128(9):944-53.
Score: 0.082
-
Ethnic differences in atrial fibrillation identified using implanted cardiac devices. J Cardiovasc Electrophysiol. 2013 Apr; 24(4):381-7.
Score: 0.079
-
Comparison of fixed tilt and tuned defibrillation waveforms: the PROMISE study. J Cardiovasc Electrophysiol. 2013 Mar; 24(3):323-7.
Score: 0.078
-
Atrial overdrive pacing to prevent atrial fibrillation: insights from ASSERT. Heart Rhythm. 2012 Oct; 9(10):1667-73.
Score: 0.076
-
Sites of left and right ventricular lead implantation and response to cardiac resynchronization therapy observations from the REVERSE trial. Eur Heart J. 2012 Nov; 33(21):2662-71.
Score: 0.074
-
Subclinical atrial fibrillation and the risk of stroke. N Engl J Med. 2012 Jan 12; 366(2):120-9.
Score: 0.074
-
Continuous hemodynamic monitoring in patients with mild to moderate heart failure: results of The Reducing Decompensation Events Utilizing Intracardiac Pressures in Patients With Chronic Heart Failure (REDUCEhf) trial. Congest Heart Fail. 2011 Sep-Oct; 17(5):248-54.
Score: 0.072
-
The Heart Rhythm Society (HRS)/American Society of Anesthesiologists (ASA) Expert Consensus Statement on the perioperative management of patients with implantable defibrillators, pacemakers and arrhythmia monitors: facilities and patient management: executive summary this document was developed as a joint project with the American Society of Anesthesiologists (ASA), and in collaboration with the American Heart Association (AHA), and the Society of Thoracic Surgeons (STS). Heart Rhythm. 2011 Jul; 8(7):e1-18.
Score: 0.071
-
The Heart Rhythm Society (HRS)/American Society of Anesthesiologists (ASA) Expert Consensus Statement on the perioperative management of patients with implantable defibrillators, pacemakers and arrhythmia monitors: facilities and patient management this document was developed as a joint project with the American Society of Anesthesiologists (ASA), and in collaboration with the American Heart Association (AHA), and the Society of Thoracic Surgeons (STS). Heart Rhythm. 2011 Jul; 8(7):1114-54.
Score: 0.071
-
Effectiveness of Cardiac Resynchronization Therapy by QRS Morphology in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT). Circulation. 2011 Mar 15; 123(10):1061-72.
Score: 0.069
-
Cardiac resynchronization therapy in asymptomatic or mildly symptomatic heart failure patients in relation to etiology: results from the REVERSE (REsynchronization reVErses Remodeling in Systolic Left vEntricular Dysfunction) study. J Am Coll Cardiol. 2010 Nov 23; 56(22):1826-31.
Score: 0.068
-
Primary results from the SmartDelay determined AV optimization: a comparison to other AV delay methods used in cardiac resynchronization therapy (SMART-AV) trial: a randomized trial comparing empirical, echocardiography-guided, and algorithmic atrioventricular delay programming in cardiac resynchronization therapy. Circulation. 2010 Dec 21; 122(25):2660-8.
Score: 0.068
-
Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial. J Am Coll Cardiol. 2009 Nov 10; 54(20):1837-46.
Score: 0.063
-
Role of transesophageal echocardiography among patients with atrial fibrillation undergoing electrophysiology testing. Am J Cardiol. 2009 Nov 01; 104(9):1256-8.
Score: 0.063
-
Role of microvolt T-wave alternans in assessment of arrhythmia vulnerability among patients with heart failure and systolic dysfunction: primary results from the T-wave alternans sudden cardiac death in heart failure trial substudy. Circulation. 2008 Nov 11; 118(20):2022-8.
Score: 0.059
-
Use of traditional and biventricular implantable cardiac devices for primary and secondary prevention of sudden death. Cardiol Clin. 2008 Aug; 26(3):419-31, vi-vii.
Score: 0.058
-
Pacing Evaluation-Atrial SUpport Study in Cardiac Resynchronization Therapy (PEGASUS CRT): design and rationale. Am Heart J. 2007 Jan; 153(1):7-13.
Score: 0.052
-
Serial evaluation of atrial tachyarrhythmia burden and frequency after implantation of a dual-chamber cardioverter-defibrillator. J Cardiovasc Electrophysiol. 2005 Jul; 16(7):708-13.
Score: 0.047
-
Seasonal variation of mortality in the Antiarrhythmics Versus Implantable Defibrillators (AVID) study registry. Heart Rhythm. 2004 Oct; 1(4):435-40.
Score: 0.044
-
Enhanced detection of arrhythmia vulnerability using T wave alternans, left ventricular ejection fraction, and programmed ventricular stimulation: a prospective study in subjects with chronic ischemic heart disease. J Cardiovasc Electrophysiol. 2004 Feb; 15(2):170-6.
Score: 0.042
-
Prevalence of sensing abnormalities in dual chamber implantable cardioverter defibrillators. Ann Noninvasive Electrocardiol. 2003 Jul; 8(3):219-26.
Score: 0.041
-
Effect of an implantable cardioverter defibrillator with atrial detection and shock therapies on patient-perceived, health-related quality of life. Am Heart J. 2003 May; 145(5):841-6.
Score: 0.040
-
T wave alternans for ventricular arrhythmia risk stratification. Curr Opin Cardiol. 2003 Jan; 18(1):1-5.
Score: 0.039
-
Influence of QRS duration on the prognostic value of T wave alternans. J Cardiovasc Electrophysiol. 2002 Aug; 13(8):770-5.
Score: 0.038
-
Effect of implantable defibrillators on arrhythmic events and mortality in the multicenter unsustained tachycardia trial. Circulation. 2002 Jul 09; 106(2):233-8.
Score: 0.038
-
T wave alternans for ventricular arrhythmia risk stratification. Curr Opin Cardiol. 2002 Jan; 17(1):1-5.
Score: 0.037
-
Electrical storm presages nonsudden death: the antiarrhythmics versus implantable defibrillators (AVID) trial. Circulation. 2001 Apr 24; 103(16):2066-71.
Score: 0.035
-
Correlation waveform analysis of the atrial signal: the shape of things to come? J Cardiovasc Electrophysiol. 2001 Feb; 12(2):150-2.
Score: 0.035
-
Lead- and device-related complications in the antiarrhythmics versus implantable defibrillators trial. Am Heart J. 2001 Jan; 141(1):92-8.
Score: 0.034
-
Intravenous amiodarone suppression of electrical storm refractory to chronic oral amiodarone. Pacing Clin Electrophysiol. 1999 Apr; 22(4 Pt 1):665-7.
Score: 0.030
-
The effect of delivered energy on defibrillation shock impedance. J Interv Card Electrophysiol. 1998 Sep; 2(3):273-7.
Score: 0.029
-
Lidocaine-related increase in defibrillation threshold. Anesth Analg. 1997 Aug; 85(2):299-300.
Score: 0.027
-
The Role of I-123 Metaiodobenzylguanidine Imaging in Management of Patients With Heart Failure. Am J Cardiol. 2015 Oct 15; 116 Suppl 1:S1-9.
Score: 0.024
-
An individual patient meta-analysis of five randomized trials assessing the effects of cardiac resynchronization therapy on morbidity and mortality in patients with symptomatic heart failure. Eur Heart J. 2013 Dec; 34(46):3547-56.
Score: 0.021
-
Do Beta-blockers impact microvolt T-wave alternans testing in patients at risk for ventricular arrhythmias? A meta-analysis. J Cardiovasc Electrophysiol. 2010 Sep; 21(9):1009-14.
Score: 0.017
-
Limitations of ejection fraction for prediction of sudden death risk in patients with coronary artery disease: lessons from the MUSTT study. J Am Coll Cardiol. 2007 Sep 18; 50(12):1150-7.
Score: 0.014
-
Preventing tomorrow's sudden cardiac death today: part II: Translating sudden cardiac death risk assessment strategies into practice and policy. Am Heart J. 2007 Jun; 153(6):951-9.
Score: 0.013